The title heterocyclic 1,3,4-oxadiazole derivatives differ from each other in the groups attached to the carbon atoms: a methoxyphenyl ring and a benzonitrile group in (I) and a chlorophenyl ring and an acetamide group in (II).
Keywords: crystal structure, oxadiazole derivatives, superposition, intramolecular C—H⋯O interactions, intermolecular C—H⋯N and N—H⋯N hydrogen bonds
Abstract
The title compounds, C18H15N3O4 and C17H14ClN3O3, are heterocyclic 1,3,4-oxadiazole derivatives which differ from each other in the groups attached to the carbon atoms: a methoxyphenyl ring and a benzonitrile group in (I) and a chlorophenyl ring and an acetamide group in (II). Short intramolecular C—H⋯O hydrogen bonds occur in both molecules. The crystal structure of (I) features C—H⋯N hydrogen bonds, while in the crystal structure of (II), N—H⋯N, C—H⋯N and C—H⋯O hydrogen bonds are observed.
Chemical context
Oxadiazole is a versatile heterocyclic nucleus, which has attracted a wide attention of the medicinal chemists for the development of new drugs. Compounds containing a heterocyclic ring system are of great importance both medicinally and industrially (Pace & Pierro, 2009 ▸). This stable and neutral hetero aromatic nucleus is associated with potent pharmacological activity that can be attributed to the presence of the toxophoric —N=C—O— linkage (Rigo & Couturier, 1985 ▸). Furthermore, 1,3,4-oxadiazole heterocycles are very good bioisosteres of amides and esters, which can contribute substantially in increasing pharmacological activity by participating in hydrogen-bonding interactions with the receptors (Guimaraes et al., 2005 ▸). In view of the above importance of the title compounds, we have undertaken single-crystal X-ray diffraction studies for the both compounds and the results are presented here.
Structural commentary
The molecular structures of (I) and (II) are illustrated in Figs. 1 ▸ and 2 ▸, respectively. In (I), the 4-methoxyphenyl and oxadiazole (r.m.s. deviation 0.007 Å) rings are almost coplanar with a dihedral angle of 1.4 (1)°. The methoxy atoms O4 and C16 are also coplanar with the rings, deviating by 0.080 (1) and 0.020 (1) Å from the mean plane of the phenyl ring, respectively. In (II), the chlorophenyl ring is almost coplanar with the oxadiazole ring, the angle between their mean planes being 4.0 (1)°. The whole molecule is almost planar: the r.m.s. deviation is 0.098 Å and the largest deviation from the mean plane of 0.230 (2) Å is observed for atom C17. Such planarity is not observed in (I) since the methoxyphenyl ring and the benzonitrile moiety are oriented at a dihedral angle of 66.8 (1)°. This difference can be seen in Fig. 3 ▸, which shows a superposition of the two molecular structures through the oxadiazole ring (C7/N1/N2/C8/O1) obtained using Qmol (Gans & Shalloway, 2001 ▸).
Figure 1.
A view of the molecular structure of compound (I), showing the atom labelling. Displacement ellipsoids are drawn at the 30% probability level. The dashed line represent the intramolecular C—H⋯O interaction (Table 1 ▸).
Figure 2.
A view of the molecular structure of compound (II), showing the atom labelling. Displacement ellipsoids are drawn at the 30% probability level. The dashed line represents the intramolecular C—H⋯O interaction (Table 2 ▸).
Figure 3.
Superposition of oxadiazole ring system of compound (I) (blue) and compound (II)(red).
The molecular structures of both (1) and (II) are influenced by intramolecular C—H⋯O interactions (Tables 1 ▸ and 2 ▸), which form S(5) ring motifs (Figs. 1 ▸ and 2 ▸).
Table 1. Hydrogen-bond geometry (Å, °) for (I) .
D—H⋯A | D—H | H⋯A | D⋯A | D—H⋯A |
---|---|---|---|---|
C1—H1⋯O1 | 0.93 | 2.50 | 2.835 (6) | 101 |
C9—H9A⋯N1i | 0.97 | 2.57 | 3.540 (6) | 178 |
C18—H18A⋯N2ii | 0.96 | 2.60 | 3.470 (6) | 151 |
C16—H16B⋯O3iii | 0.96 | 2.59 | 3.094 (7) | 113 |
Symmetry codes: (i) ; (ii)
; (iii)
.
Table 2. Hydrogen-bond geometry (Å, °) for (II) .
D—H⋯A | D—H | H⋯A | D⋯A | D—H⋯A |
---|---|---|---|---|
C1—H1⋯O1 | 0.93 | 2.54 | 2.853 (3) | 100 |
N3—H3⋯N2i | 0.86 | 2.55 | 3.377 (3) | 161 |
C1—H1⋯O3i | 0.93 | 2.46 | 3.359 (3) | 163 |
C14—H14⋯N2i | 0.93 | 2.59 | 3.443 (3) | 152 |
C17—H17C⋯O3ii | 0.96 | 2.56 | 3.357 (4) | 140 |
Symmetry codes: (i) ; (ii)
.
Supramolecular features
In the crystal of compound (I), molecules are associated via C—H⋯O interactions into inversion dimers (C16—H16B⋯O3iii, Table 1 ▸), generating an (30) motif (Fig. 4 ▸). Further C—H⋯N hydrogen bonds (C9—H9A⋯N1i, Table 1 ▸) link the molecules, forming C(5) chains propagating along [010] (Fig. 5 ▸). There is also a weak C—H⋯N interaction (C18—H18A⋯N2ii, Table 1 ▸) that links the molecules, forming C(9) chains propagating in an anti-parallel manner along [110]. These C—H⋯N hydrogen bonds along with the C—H⋯O dimers form a closed cavity shape arrangement consisting of 26 atoms in the unit cell (Fig. 6 ▸). In addition, offset π–π interactions are observed between the centroids of inversion-related oxadiazole and 4-methoxyphenyl rings with a centroid–centroid distance of 3.700 (3) Å and a slippage of 1.037 Å.
Figure 4.
The inversion dimer formed in compound (I) via C—H⋯O interactions (dashed lines). For clarity H atoms not involved in these hydrogen bonds have been omitted.
Figure 5.
The crystal packing of compound (I) viewed down the b axis. The C—H⋯N hydrogen bonds (see Table 1 ▸) are shown as dashed lines. For clarity H atoms not involved in these hydrogen bonds have been omitted.
Figure 6.
The crystal packing of the title compound (I) viewed along the a axis. The C—H⋯N hydrogen bonds and C—H⋯O interactions (see Table 1 ▸) are shown as dashed lines. For clarity H atoms not involved in these hydrogen bonds have been omitted.
In the crystal of compound (II), molecules are connected by N—H⋯N hydrogen bonds forming C(10) chains, C—H⋯N hydrogen bonds forming C(8) chains and C—H⋯O interactions forming C(15) chains (Fig. 7 ▸). All these chains propagate along [010] in a helical manner. In addition, C—H⋯O interactions involving atoms H17C and O3 are also observed (Table 2 ▸). No π–π interactions are observed in compound (II) because of the coplanarity between the oxadiazole and chlorophenyl rings.
Figure 7.
The crystal packing of (II) viewed along the c axis. The N—H⋯N, C—H⋯N and C—H⋯O interactions (see Table 2 ▸) are shown as dashed lines. For clarity H atoms not involved in these hydrogen bonds have been omitted.
Synthesis and crystallization
Compound (I) was synthesized from a solution of 4-hydroxy-3-methoxybenzonitrile (1mmol), K2CO3 (3 mmol) in DMF (4 mL), 2-(chloromethyl)-5-(4-methoxyphenyl)-1,3,4-oxadiazole and KI (0.5 mmol). The reaction mixture was stirred at room temperature for about 2 h until the starting material had been consumed (TLC monitoring), and then washed with cold water. The solid product was collected by filtration and dried under vacuum. The pure compound was further recrystallized from ethyl acetate/petroleum ether solution (v:v = 1:1).
Compound (II) was synthesized from a solution of N-(4-hydroxyphenyl)acetamide (1mmol), K2CO3 (3 mmol) in ACN (5mL), 2-(chloromethyl)-5-(4-chlorophenyl)-1,3,4-oxadiazole and KI (0.5 mmol). The reaction mixture was stirred under reflux condition for about 16 h, until completion of the reaction (TLC monitoring), then it was diluted with ethyl acetate (30 mL) and washed with saturated NaHCO3 and cold water. The organic layer was separated, dried over anhydrous Na2SO4 and concentrated under vacuum. The pure compound was further recrystallized from an ethyl acetate/petroleum ether solution (v:v = 1:1), giving colourless block-like crystals suitable for X-ray diffraction analysis.
Refinement
Crystal data, data collection and structure refinement details are summarized in Table 3 ▸. In both crystal structures, H atoms were placed in idealized positions and allowed to ride on their parent atoms: C—H = 0.93–0.97 Å with U iso(H) = 1.5U eq(C-methyl) and 1.2U eq(C) for other H atoms.
Table 3. Experimental details.
(I) | (II) | |
---|---|---|
Crystal data | ||
Chemical formula | C18H15N3O4 | C17H14ClN3O3 |
M r | 337.33 | 343.76 |
Crystal system, space group | Triclinic, P
![]() |
Monoclinic, C2/c |
Temperature (K) | 298 | 298 |
a, b, c (Å) | 6.0847 (14), 8.5048 (19), 17.286 (4) | 42.24 (1), 10.233 (3), 7.496 (2) |
α, β, γ (°) | 102.668 (7), 90.646 (6), 109.813 (8) | 90, 91.016 (11), 90 |
V (Å3) | 817.5 (3) | 3239.6 (15) |
Z | 2 | 8 |
Radiation type | Mo Kα | Mo Kα |
μ (mm−1) | 0.10 | 0.26 |
Crystal size (mm) | 0.24 × 0.21 × 0.19 | 0.22 × 0.20 × 0.18 |
Data collection | ||
Diffractometer | Bruker SMART APEX CCD area-detector | Bruker SMART APEX CCD area-detector |
No. of measured, independent and observed [I > 2σ(I)] reflections | 4701, 3593, 1137 | 8758, 3650, 2733 |
R int | 0.087 | 0.117 |
(sin θ/λ)max (Å−1) | 0.650 | 0.649 |
Refinement | ||
R[F 2 > 2σ(F 2)], wR(F 2), S | 0.086, 0.282, 0.95 | 0.063, 0.182, 1.05 |
No. of reflections | 3593 | 3650 |
No. of parameters | 228 | 218 |
H-atom treatment | H-atom parameters constrained | H-atom parameters constrained |
Δρmax, Δρmin (e Å−3) | 0.49, −0.33 | 0.25, −0.36 |
Supplementary Material
Crystal structure: contains datablock(s) I, II, global. DOI: 10.1107/S2056989018016754/zq2243sup1.cif
Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989018016754/zq2243Isup2.hkl
Structure factors: contains datablock(s) II. DOI: 10.1107/S2056989018016754/zq2243IIsup4.hkl
Supporting information file. DOI: 10.1107/S2056989018016754/zq2243Isup4.cml
Supporting information file. DOI: 10.1107/S2056989018016754/zq2243IIsup5.cml
Additional supporting information: crystallographic information; 3D view; checkCIF report
supplementary crystallographic information
3-Methoxy-4-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}benzonitrile (I). Crystal data
C18H15N3O4 | Z = 2 |
Mr = 337.33 | F(000) = 352 |
Triclinic, P1 | Dx = 1.370 Mg m−3 |
a = 6.0847 (14) Å | Mo Kα radiation, λ = 0.71073 Å |
b = 8.5048 (19) Å | Cell parameters from 3118 reflections |
c = 17.286 (4) Å | θ = 3.2–27.4° |
α = 102.668 (7)° | µ = 0.10 mm−1 |
β = 90.646 (6)° | T = 298 K |
γ = 109.813 (8)° | Block, colourless |
V = 817.5 (3) Å3 | 0.24 × 0.21 × 0.19 mm |
3-Methoxy-4-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}benzonitrile (I). Data collection
Bruker SMART APEX CCD area-detector diffractometer | Rint = 0.087 |
Radiation source: fine-focus sealed tube | θmax = 27.5°, θmin = 3.1° |
ω and φ scans | h = −7→7 |
4701 measured reflections | k = −9→10 |
3593 independent reflections | l = −22→14 |
1137 reflections with I > 2σ(I) |
3-Methoxy-4-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}benzonitrile (I). Refinement
Refinement on F2 | 0 restraints |
Least-squares matrix: full | Hydrogen site location: inferred from neighbouring sites |
R[F2 > 2σ(F2)] = 0.086 | H-atom parameters constrained |
wR(F2) = 0.282 | w = 1/[σ2(Fo2) + (0.0956P)2] where P = (Fo2 + 2Fc2)/3 |
S = 0.95 | (Δ/σ)max < 0.001 |
3593 reflections | Δρmax = 0.49 e Å−3 |
228 parameters | Δρmin = −0.32 e Å−3 |
3-Methoxy-4-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}benzonitrile (I). Special details
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. |
3-Methoxy-4-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}benzonitrile (I). Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
x | y | z | Uiso*/Ueq | ||
O1 | 0.1843 (5) | 0.2454 (3) | 0.36727 (18) | 0.0573 (8) | |
O2 | −0.1120 (5) | 0.0785 (3) | 0.21803 (19) | 0.0672 (10) | |
O3 | −0.2533 (6) | −0.2488 (4) | 0.16208 (19) | 0.0661 (10) | |
O4 | 0.6234 (7) | 0.1389 (5) | 0.6784 (2) | 0.0999 (13) | |
N1 | 0.5537 (7) | 0.3888 (5) | 0.3540 (2) | 0.0666 (11) | |
N2 | 0.4067 (7) | 0.3864 (5) | 0.2876 (2) | 0.0679 (12) | |
N3 | −1.0776 (8) | −0.3032 (5) | −0.0393 (3) | 0.0818 (14) | |
C1 | 0.3016 (9) | 0.1713 (6) | 0.5111 (3) | 0.0746 (15) | |
H1 | 0.145930 | 0.131974 | 0.490115 | 0.089* | |
C2 | 0.3548 (10) | 0.1334 (7) | 0.5810 (3) | 0.0810 (17) | |
H2 | 0.235535 | 0.069914 | 0.606852 | 0.097* | |
C3 | 0.5834 (10) | 0.1892 (7) | 0.6124 (3) | 0.0737 (15) | |
C4 | 0.7621 (9) | 0.2890 (7) | 0.5738 (3) | 0.0744 (15) | |
H4 | 0.917781 | 0.329479 | 0.594902 | 0.089* | |
C5 | 0.7024 (9) | 0.3258 (6) | 0.5045 (3) | 0.0734 (14) | |
H5 | 0.820509 | 0.392725 | 0.479518 | 0.088* | |
C6 | 0.4759 (7) | 0.2674 (5) | 0.4710 (3) | 0.0534 (11) | |
C7 | 0.4163 (7) | 0.3047 (5) | 0.3975 (3) | 0.0563 (12) | |
C8 | 0.1976 (8) | 0.3015 (5) | 0.2998 (3) | 0.0510 (11) | |
C9 | −0.0194 (8) | 0.2584 (5) | 0.2476 (3) | 0.0617 (13) | |
H9A | −0.132615 | 0.297492 | 0.277473 | 0.074* | |
H9B | 0.015621 | 0.314695 | 0.203787 | 0.074* | |
C10 | −0.3104 (7) | 0.0114 (5) | 0.1662 (3) | 0.0524 (11) | |
C11 | −0.4371 (8) | 0.1049 (5) | 0.1460 (3) | 0.0559 (12) | |
H11 | −0.387569 | 0.222949 | 0.167178 | 0.067* | |
C12 | −0.6385 (8) | 0.0239 (6) | 0.0940 (3) | 0.0572 (12) | |
H12 | −0.723785 | 0.087491 | 0.080049 | 0.069* | |
C13 | −0.7123 (8) | −0.1506 (6) | 0.0632 (2) | 0.0531 (11) | |
C14 | −0.5881 (7) | −0.2481 (5) | 0.0840 (2) | 0.0545 (12) | |
H14 | −0.640032 | −0.366455 | 0.063238 | 0.065* | |
C15 | −0.3888 (8) | −0.1680 (5) | 0.1354 (3) | 0.0545 (12) | |
C16 | 0.8476 (11) | 0.1995 (8) | 0.7151 (4) | 0.110 (2) | |
H16A | 0.939257 | 0.139919 | 0.684979 | 0.165* | |
H16B | 0.842598 | 0.180561 | 0.767860 | 0.165* | |
H16C | 0.917417 | 0.320492 | 0.718006 | 0.165* | |
C17 | −0.9170 (9) | −0.2349 (6) | 0.0064 (3) | 0.0621 (13) | |
C18 | −0.3336 (9) | −0.4316 (5) | 0.1354 (3) | 0.0741 (15) | |
H18A | −0.454760 | −0.482003 | 0.166887 | 0.111* | |
H18B | −0.205201 | −0.471141 | 0.140725 | 0.111* | |
H18C | −0.394768 | −0.464801 | 0.080479 | 0.111* |
3-Methoxy-4-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}benzonitrile (I). Atomic displacement parameters (Å2)
U11 | U22 | U33 | U12 | U13 | U23 | |
O1 | 0.0402 (18) | 0.0536 (18) | 0.059 (2) | −0.0017 (14) | −0.0116 (15) | 0.0045 (15) |
O2 | 0.062 (2) | 0.0410 (16) | 0.081 (2) | 0.0082 (15) | −0.0299 (18) | −0.0021 (16) |
O3 | 0.065 (2) | 0.0469 (18) | 0.075 (2) | 0.0105 (15) | −0.0204 (18) | 0.0094 (16) |
O4 | 0.087 (3) | 0.126 (3) | 0.086 (3) | 0.039 (3) | −0.016 (2) | 0.023 (3) |
N1 | 0.044 (2) | 0.072 (3) | 0.061 (3) | −0.002 (2) | 0.002 (2) | 0.003 (2) |
N2 | 0.059 (3) | 0.069 (3) | 0.055 (3) | 0.000 (2) | 0.004 (2) | 0.010 (2) |
N3 | 0.078 (3) | 0.074 (3) | 0.078 (3) | 0.013 (3) | −0.027 (3) | 0.010 (2) |
C1 | 0.063 (3) | 0.078 (3) | 0.068 (3) | 0.014 (3) | −0.021 (3) | 0.009 (3) |
C2 | 0.066 (4) | 0.098 (4) | 0.073 (4) | 0.015 (3) | −0.003 (3) | 0.029 (3) |
C3 | 0.074 (4) | 0.083 (4) | 0.065 (3) | 0.037 (3) | −0.007 (3) | 0.005 (3) |
C4 | 0.049 (3) | 0.089 (4) | 0.070 (4) | 0.025 (3) | −0.021 (3) | −0.010 (3) |
C5 | 0.047 (3) | 0.078 (3) | 0.073 (4) | 0.009 (3) | −0.011 (3) | −0.004 (3) |
C6 | 0.042 (3) | 0.049 (2) | 0.054 (3) | 0.007 (2) | −0.005 (2) | −0.005 (2) |
C7 | 0.035 (2) | 0.047 (2) | 0.064 (3) | 0.002 (2) | −0.006 (2) | −0.013 (2) |
C8 | 0.054 (3) | 0.041 (2) | 0.048 (3) | 0.012 (2) | 0.002 (2) | −0.002 (2) |
C9 | 0.063 (3) | 0.041 (2) | 0.069 (3) | 0.013 (2) | −0.020 (3) | −0.004 (2) |
C10 | 0.048 (3) | 0.039 (2) | 0.059 (3) | 0.009 (2) | −0.013 (2) | 0.002 (2) |
C11 | 0.062 (3) | 0.043 (2) | 0.057 (3) | 0.014 (2) | −0.008 (2) | 0.008 (2) |
C12 | 0.051 (3) | 0.058 (3) | 0.062 (3) | 0.018 (2) | −0.005 (2) | 0.014 (2) |
C13 | 0.049 (3) | 0.058 (3) | 0.041 (2) | 0.007 (2) | −0.002 (2) | 0.007 (2) |
C14 | 0.055 (3) | 0.048 (2) | 0.050 (3) | 0.009 (2) | −0.011 (2) | 0.004 (2) |
C15 | 0.051 (3) | 0.045 (2) | 0.060 (3) | 0.013 (2) | −0.013 (2) | 0.006 (2) |
C16 | 0.093 (5) | 0.145 (6) | 0.077 (4) | 0.033 (4) | −0.019 (4) | 0.015 (4) |
C17 | 0.063 (3) | 0.053 (3) | 0.061 (3) | 0.013 (2) | −0.011 (3) | 0.008 (2) |
C18 | 0.087 (4) | 0.049 (3) | 0.087 (4) | 0.020 (3) | 0.006 (3) | 0.022 (3) |
3-Methoxy-4-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}benzonitrile (I). Geometric parameters (Å, º)
O1—C8 | 1.347 (5) | C5—H5 | 0.9300 |
O1—C7 | 1.381 (5) | C6—C7 | 1.446 (6) |
O2—C10 | 1.368 (5) | C8—C9 | 1.480 (6) |
O2—C9 | 1.409 (5) | C9—H9A | 0.9700 |
O3—C15 | 1.371 (5) | C9—H9B | 0.9700 |
O3—C18 | 1.426 (5) | C10—C11 | 1.371 (5) |
O4—C3 | 1.350 (6) | C10—C15 | 1.409 (5) |
O4—C16 | 1.375 (6) | C11—C12 | 1.383 (6) |
N1—C7 | 1.274 (5) | C11—H11 | 0.9300 |
N1—N2 | 1.439 (5) | C12—C13 | 1.373 (6) |
N2—C8 | 1.278 (5) | C12—H12 | 0.9300 |
N3—C17 | 1.146 (5) | C13—C14 | 1.392 (5) |
C1—C2 | 1.380 (6) | C13—C17 | 1.445 (6) |
C1—C6 | 1.396 (6) | C14—C15 | 1.369 (5) |
C1—H1 | 0.9300 | C14—H14 | 0.9300 |
C2—C3 | 1.370 (7) | C16—H16A | 0.9600 |
C2—H2 | 0.9300 | C16—H16B | 0.9600 |
C3—C4 | 1.409 (7) | C16—H16C | 0.9600 |
C4—C5 | 1.377 (6) | C18—H18A | 0.9600 |
C4—H4 | 0.9300 | C18—H18B | 0.9600 |
C5—C6 | 1.369 (6) | C18—H18C | 0.9600 |
C8—O1—C7 | 102.6 (3) | C8—C9—H9B | 110.0 |
C10—O2—C9 | 117.8 (3) | H9A—C9—H9B | 108.4 |
C15—O3—C18 | 116.4 (3) | C11—C10—O2 | 124.7 (4) |
C3—O4—C16 | 119.1 (5) | C11—C10—C15 | 119.8 (4) |
C7—N1—N2 | 106.0 (4) | O2—C10—C15 | 115.4 (3) |
C8—N2—N1 | 105.4 (4) | C10—C11—C12 | 120.2 (4) |
C2—C1—C6 | 121.6 (5) | C10—C11—H11 | 119.9 |
C2—C1—H1 | 119.2 | C12—C11—H11 | 119.9 |
C6—C1—H1 | 119.2 | C13—C12—C11 | 119.8 (4) |
C1—C2—C3 | 120.0 (5) | C13—C12—H12 | 120.1 |
C1—C2—H2 | 120.0 | C11—C12—H12 | 120.1 |
C3—C2—H2 | 120.0 | C12—C13—C14 | 120.9 (4) |
O4—C3—C2 | 116.6 (5) | C12—C13—C17 | 120.1 (4) |
O4—C3—C4 | 123.8 (5) | C14—C13—C17 | 119.0 (4) |
C2—C3—C4 | 119.5 (5) | C15—C14—C13 | 119.3 (4) |
C5—C4—C3 | 118.9 (5) | C15—C14—H14 | 120.4 |
C5—C4—H4 | 120.5 | C13—C14—H14 | 120.4 |
C3—C4—H4 | 120.5 | O3—C15—C14 | 125.3 (4) |
C6—C5—C4 | 122.5 (5) | O3—C15—C10 | 114.7 (4) |
C6—C5—H5 | 118.8 | C14—C15—C10 | 120.0 (4) |
C4—C5—H5 | 118.8 | O4—C16—H16A | 109.5 |
C5—C6—C1 | 117.5 (5) | O4—C16—H16B | 109.5 |
C5—C6—C7 | 121.9 (5) | H16A—C16—H16B | 109.5 |
C1—C6—C7 | 120.7 (4) | O4—C16—H16C | 109.5 |
N1—C7—O1 | 112.4 (4) | H16A—C16—H16C | 109.5 |
N1—C7—C6 | 128.2 (4) | H16B—C16—H16C | 109.5 |
O1—C7—C6 | 119.4 (4) | N3—C17—C13 | 179.0 (6) |
N2—C8—O1 | 113.6 (4) | O3—C18—H18A | 109.5 |
N2—C8—C9 | 127.0 (4) | O3—C18—H18B | 109.5 |
O1—C8—C9 | 119.4 (4) | H18A—C18—H18B | 109.5 |
O2—C9—C8 | 108.3 (3) | O3—C18—H18C | 109.5 |
O2—C9—H9A | 110.0 | H18A—C18—H18C | 109.5 |
C8—C9—H9A | 110.0 | H18B—C18—H18C | 109.5 |
O2—C9—H9B | 110.0 | ||
C7—N1—N2—C8 | 0.3 (5) | C7—O1—C8—N2 | −0.5 (5) |
C6—C1—C2—C3 | −0.5 (8) | C7—O1—C8—C9 | 178.1 (3) |
C16—O4—C3—C2 | −176.1 (5) | C10—O2—C9—C8 | −178.1 (4) |
C16—O4—C3—C4 | 5.9 (8) | N2—C8—C9—O2 | 114.2 (5) |
C1—C2—C3—O4 | −176.3 (5) | O1—C8—C9—O2 | −64.2 (5) |
C1—C2—C3—C4 | 1.7 (8) | C9—O2—C10—C11 | −5.7 (7) |
O4—C3—C4—C5 | 176.8 (5) | C9—O2—C10—C15 | 176.9 (4) |
C2—C3—C4—C5 | −1.1 (8) | O2—C10—C11—C12 | −178.7 (4) |
C3—C4—C5—C6 | −0.7 (8) | C15—C10—C11—C12 | −1.4 (7) |
C4—C5—C6—C1 | 1.8 (7) | C10—C11—C12—C13 | 0.4 (7) |
C4—C5—C6—C7 | −179.0 (4) | C11—C12—C13—C14 | 0.6 (7) |
C2—C1—C6—C5 | −1.2 (7) | C11—C12—C13—C17 | −177.4 (4) |
C2—C1—C6—C7 | 179.6 (4) | C12—C13—C14—C15 | −0.6 (7) |
N2—N1—C7—O1 | −0.7 (5) | C17—C13—C14—C15 | 177.5 (4) |
N2—N1—C7—C6 | 179.2 (4) | C18—O3—C15—C14 | −2.0 (7) |
C8—O1—C7—N1 | 0.8 (5) | C18—O3—C15—C10 | 176.9 (4) |
C8—O1—C7—C6 | −179.2 (4) | C13—C14—C15—O3 | 178.5 (4) |
C5—C6—C7—N1 | 1.4 (7) | C13—C14—C15—C10 | −0.4 (7) |
C1—C6—C7—N1 | −179.5 (4) | C11—C10—C15—O3 | −177.6 (4) |
C5—C6—C7—O1 | −178.7 (4) | O2—C10—C15—O3 | −0.1 (6) |
C1—C6—C7—O1 | 0.5 (6) | C11—C10—C15—C14 | 1.4 (7) |
N1—N2—C8—O1 | 0.1 (5) | O2—C10—C15—C14 | 178.9 (4) |
N1—N2—C8—C9 | −178.3 (4) |
3-Methoxy-4-{[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methoxy}benzonitrile (I). Hydrogen-bond geometry (Å, º)
D—H···A | D—H | H···A | D···A | D—H···A |
C1—H1···O1 | 0.93 | 2.50 | 2.835 (6) | 101 |
C9—H9A···N1i | 0.97 | 2.57 | 3.540 (6) | 178 |
C18—H18A···N2ii | 0.96 | 2.60 | 3.470 (6) | 151 |
C16—H16B···O3iii | 0.96 | 2.59 | 3.094 (7) | 113 |
Symmetry codes: (i) x−1, y, z; (ii) x−1, y−1, z; (iii) −x+1, −y, −z+1.
N-(4-{[5-(4-Chlorophenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)acetamide (II) . Crystal data
C17H14ClN3O3 | F(000) = 1424 |
Mr = 343.76 | Dx = 1.410 Mg m−3 |
Monoclinic, C2/c | Mo Kα radiation, λ = 0.71073 Å |
a = 42.24 (1) Å | Cell parameters from 5528 reflections |
b = 10.233 (3) Å | θ = 3.3–27.2° |
c = 7.496 (2) Å | µ = 0.26 mm−1 |
β = 91.016 (11)° | T = 298 K |
V = 3239.6 (15) Å3 | Block, colourless |
Z = 8 | 0.22 × 0.20 × 0.18 mm |
N-(4-{[5-(4-Chlorophenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)acetamide (II) . Data collection
Bruker SMART APEX CCD area-detector diffractometer | Rint = 0.117 |
Radiation source: fine-focus sealed tube | θmax = 27.5°, θmin = 3.1° |
ω and φ scans | h = −52→54 |
8758 measured reflections | k = −13→12 |
3650 independent reflections | l = −6→9 |
2733 reflections with I > 2σ(I) |
N-(4-{[5-(4-Chlorophenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)acetamide (II) . Refinement
Refinement on F2 | 0 restraints |
Least-squares matrix: full | Hydrogen site location: inferred from neighbouring sites |
R[F2 > 2σ(F2)] = 0.063 | H-atom parameters constrained |
wR(F2) = 0.182 | w = 1/[σ2(Fo2) + (0.0635P)2 + 1.9656P] where P = (Fo2 + 2Fc2)/3 |
S = 1.05 | (Δ/σ)max = 0.002 |
3650 reflections | Δρmax = 0.25 e Å−3 |
218 parameters | Δρmin = −0.36 e Å−3 |
N-(4-{[5-(4-Chlorophenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)acetamide (II) . Special details
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes. |
N-(4-{[5-(4-Chlorophenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)acetamide (II) . Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)
x | y | z | Uiso*/Ueq | ||
Cl1 | 1.01226 (2) | 0.28663 (15) | −0.00562 (17) | 0.1223 (5) | |
O1 | 0.85574 (3) | 0.18095 (14) | 0.0915 (2) | 0.0407 (4) | |
O2 | 0.77454 (3) | 0.07687 (14) | 0.0967 (2) | 0.0425 (4) | |
O3 | 0.62394 (4) | 0.0180 (2) | 0.2485 (3) | 0.0729 (6) | |
N1 | 0.86735 (5) | −0.00435 (19) | −0.0435 (3) | 0.0519 (5) | |
N2 | 0.83462 (4) | −0.00355 (19) | −0.0042 (3) | 0.0487 (5) | |
N3 | 0.65271 (4) | 0.19545 (18) | 0.3324 (3) | 0.0446 (4) | |
H3 | 0.651157 | 0.270429 | 0.383345 | 0.053* | |
C1 | 0.91898 (6) | 0.2770 (3) | 0.0713 (4) | 0.0552 (6) | |
H1 | 0.903405 | 0.332106 | 0.114707 | 0.066* | |
C2 | 0.95026 (7) | 0.3187 (3) | 0.0652 (4) | 0.0723 (8) | |
H2 | 0.955862 | 0.401652 | 0.105345 | 0.087* | |
C3 | 0.97283 (6) | 0.2357 (4) | −0.0008 (4) | 0.0742 (9) | |
C4 | 0.96543 (6) | 0.1127 (4) | −0.0627 (4) | 0.0737 (8) | |
H4 | 0.981049 | 0.058641 | −0.108061 | 0.088* | |
C5 | 0.93441 (6) | 0.0710 (3) | −0.0564 (4) | 0.0623 (7) | |
H5 | 0.929027 | −0.011804 | −0.097927 | 0.075* | |
C6 | 0.91116 (5) | 0.1521 (2) | 0.0118 (3) | 0.0462 (5) | |
C7 | 0.87852 (5) | 0.1050 (2) | 0.0164 (3) | 0.0417 (5) | |
C8 | 0.82940 (5) | 0.1064 (2) | 0.0735 (3) | 0.0392 (5) | |
C9 | 0.79968 (5) | 0.1607 (2) | 0.1473 (3) | 0.0395 (5) | |
H9A | 0.801380 | 0.166062 | 0.276309 | 0.047* | |
H9B | 0.795908 | 0.247872 | 0.100672 | 0.047* | |
C10 | 0.74482 (5) | 0.11247 (18) | 0.1555 (3) | 0.0345 (4) | |
C11 | 0.72024 (5) | 0.02966 (19) | 0.1083 (3) | 0.0376 (4) | |
H11 | 0.724354 | −0.043669 | 0.039235 | 0.045* | |
C12 | 0.68942 (5) | 0.05388 (19) | 0.1623 (3) | 0.0393 (5) | |
H12 | 0.673114 | −0.002716 | 0.129254 | 0.047* | |
C13 | 0.68317 (5) | 0.16400 (19) | 0.2665 (3) | 0.0356 (4) | |
C14 | 0.70774 (5) | 0.24918 (19) | 0.3082 (3) | 0.0377 (4) | |
H14 | 0.703636 | 0.324139 | 0.374048 | 0.045* | |
C15 | 0.73839 (5) | 0.22421 (19) | 0.2532 (3) | 0.0376 (4) | |
H15 | 0.754604 | 0.282438 | 0.281810 | 0.045* | |
C16 | 0.62573 (5) | 0.1230 (2) | 0.3258 (3) | 0.0481 (5) | |
C17 | 0.59772 (6) | 0.1809 (3) | 0.4218 (4) | 0.0633 (7) | |
H17A | 0.579119 | 0.174637 | 0.346840 | 0.095* | |
H17B | 0.601896 | 0.271026 | 0.448890 | 0.095* | |
H17C | 0.594398 | 0.133676 | 0.530577 | 0.095* |
N-(4-{[5-(4-Chlorophenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)acetamide (II) . Atomic displacement parameters (Å2)
U11 | U22 | U33 | U12 | U13 | U23 | |
Cl1 | 0.0409 (4) | 0.1918 (13) | 0.1346 (10) | −0.0285 (6) | 0.0098 (5) | −0.0347 (9) |
O1 | 0.0337 (7) | 0.0388 (7) | 0.0495 (9) | 0.0005 (6) | 0.0009 (6) | 0.0002 (6) |
O2 | 0.0347 (7) | 0.0388 (7) | 0.0541 (9) | −0.0004 (6) | 0.0022 (6) | −0.0049 (6) |
O3 | 0.0530 (10) | 0.0679 (12) | 0.0983 (15) | −0.0194 (10) | 0.0142 (10) | −0.0212 (11) |
N1 | 0.0459 (10) | 0.0484 (11) | 0.0618 (12) | 0.0004 (9) | 0.0093 (9) | −0.0053 (9) |
N2 | 0.0445 (10) | 0.0434 (10) | 0.0583 (12) | −0.0042 (8) | 0.0070 (8) | −0.0058 (8) |
N3 | 0.0391 (9) | 0.0393 (9) | 0.0554 (11) | 0.0024 (8) | 0.0032 (8) | −0.0038 (8) |
C1 | 0.0397 (12) | 0.0612 (15) | 0.0648 (15) | −0.0029 (11) | 0.0036 (11) | −0.0073 (12) |
C2 | 0.0495 (15) | 0.085 (2) | 0.082 (2) | −0.0147 (14) | −0.0027 (14) | −0.0151 (17) |
C3 | 0.0378 (13) | 0.112 (3) | 0.0733 (19) | −0.0085 (15) | 0.0046 (12) | −0.0051 (18) |
C4 | 0.0419 (13) | 0.097 (2) | 0.083 (2) | 0.0130 (15) | 0.0095 (13) | −0.0038 (17) |
C5 | 0.0491 (13) | 0.0675 (16) | 0.0708 (17) | 0.0051 (12) | 0.0107 (12) | −0.0023 (13) |
C6 | 0.0377 (11) | 0.0514 (12) | 0.0495 (12) | 0.0033 (10) | 0.0006 (9) | 0.0048 (10) |
C7 | 0.0389 (11) | 0.0408 (11) | 0.0453 (11) | 0.0062 (9) | 0.0024 (8) | 0.0030 (9) |
C8 | 0.0394 (10) | 0.0375 (10) | 0.0407 (10) | −0.0029 (8) | −0.0008 (8) | 0.0062 (8) |
C9 | 0.0372 (10) | 0.0380 (10) | 0.0433 (11) | −0.0016 (8) | 0.0000 (8) | 0.0017 (8) |
C10 | 0.0357 (10) | 0.0328 (9) | 0.0349 (9) | 0.0008 (8) | −0.0011 (7) | 0.0032 (7) |
C11 | 0.0414 (10) | 0.0306 (9) | 0.0407 (10) | 0.0013 (8) | −0.0034 (8) | −0.0029 (8) |
C12 | 0.0356 (10) | 0.0363 (10) | 0.0458 (11) | −0.0044 (8) | −0.0033 (8) | −0.0015 (8) |
C13 | 0.0344 (10) | 0.0338 (9) | 0.0385 (10) | 0.0017 (8) | −0.0009 (8) | 0.0034 (8) |
C14 | 0.0430 (11) | 0.0306 (9) | 0.0393 (10) | 0.0014 (8) | −0.0002 (8) | −0.0023 (8) |
C15 | 0.0376 (10) | 0.0329 (9) | 0.0423 (11) | −0.0061 (8) | −0.0027 (8) | −0.0011 (8) |
C16 | 0.0398 (11) | 0.0518 (13) | 0.0529 (13) | −0.0011 (10) | 0.0007 (9) | 0.0055 (10) |
C17 | 0.0422 (13) | 0.0750 (18) | 0.0729 (17) | 0.0050 (12) | 0.0125 (12) | 0.0086 (14) |
N-(4-{[5-(4-Chlorophenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)acetamide (II) . Geometric parameters (Å, º)
Cl1—C3 | 1.746 (3) | C5—C6 | 1.390 (3) |
O1—C8 | 1.354 (2) | C5—H5 | 0.9300 |
O1—C7 | 1.366 (2) | C6—C7 | 1.461 (3) |
O2—C10 | 1.386 (2) | C8—C9 | 1.488 (3) |
O2—C9 | 1.412 (2) | C9—H9A | 0.9700 |
O3—C16 | 1.222 (3) | C9—H9B | 0.9700 |
N1—C7 | 1.292 (3) | C10—C11 | 1.381 (3) |
N1—N2 | 1.419 (3) | C10—C15 | 1.387 (3) |
N2—C8 | 1.288 (3) | C11—C12 | 1.392 (3) |
N3—C16 | 1.359 (3) | C11—H11 | 0.9300 |
N3—C13 | 1.423 (3) | C12—C13 | 1.399 (3) |
N3—H3 | 0.8600 | C12—H12 | 0.9300 |
C1—C2 | 1.390 (4) | C13—C14 | 1.387 (3) |
C1—C6 | 1.391 (4) | C14—C15 | 1.390 (3) |
C1—H1 | 0.9300 | C14—H14 | 0.9300 |
C2—C3 | 1.376 (4) | C15—H15 | 0.9300 |
C2—H2 | 0.9300 | C16—C17 | 1.516 (3) |
C3—C4 | 1.375 (5) | C17—H17A | 0.9600 |
C4—C5 | 1.380 (4) | C17—H17B | 0.9600 |
C4—H4 | 0.9300 | C17—H17C | 0.9600 |
C8—O1—C7 | 102.84 (16) | O2—C9—H9A | 110.1 |
C10—O2—C9 | 115.84 (15) | C8—C9—H9A | 110.1 |
C7—N1—N2 | 105.90 (18) | O2—C9—H9B | 110.1 |
C8—N2—N1 | 105.93 (18) | C8—C9—H9B | 110.1 |
C16—N3—C13 | 128.78 (19) | H9A—C9—H9B | 108.4 |
C16—N3—H3 | 115.6 | C11—C10—O2 | 115.99 (17) |
C13—N3—H3 | 115.6 | C11—C10—C15 | 119.16 (19) |
C2—C1—C6 | 119.5 (2) | O2—C10—C15 | 124.84 (18) |
C2—C1—H1 | 120.3 | C10—C11—C12 | 121.27 (18) |
C6—C1—H1 | 120.3 | C10—C11—H11 | 119.4 |
C3—C2—C1 | 119.2 (3) | C12—C11—H11 | 119.4 |
C3—C2—H2 | 120.4 | C11—C12—C13 | 119.49 (18) |
C1—C2—H2 | 120.4 | C11—C12—H12 | 120.3 |
C4—C3—C2 | 122.1 (3) | C13—C12—H12 | 120.3 |
C4—C3—Cl1 | 118.5 (3) | C14—C13—C12 | 118.97 (19) |
C2—C3—Cl1 | 119.4 (3) | C14—C13—N3 | 117.19 (18) |
C3—C4—C5 | 118.8 (3) | C12—C13—N3 | 123.84 (18) |
C3—C4—H4 | 120.6 | C13—C14—C15 | 120.99 (18) |
C5—C4—H4 | 120.6 | C13—C14—H14 | 119.5 |
C4—C5—C6 | 120.4 (3) | C15—C14—H14 | 119.5 |
C4—C5—H5 | 119.8 | C10—C15—C14 | 120.03 (18) |
C6—C5—H5 | 119.8 | C10—C15—H15 | 120.0 |
C5—C6—C1 | 120.0 (2) | C14—C15—H15 | 120.0 |
C5—C6—C7 | 119.0 (2) | O3—C16—N3 | 122.8 (2) |
C1—C6—C7 | 120.9 (2) | O3—C16—C17 | 121.7 (2) |
N1—C7—O1 | 112.35 (19) | N3—C16—C17 | 115.5 (2) |
N1—C7—C6 | 128.0 (2) | C16—C17—H17A | 109.5 |
O1—C7—C6 | 119.63 (19) | C16—C17—H17B | 109.5 |
N2—C8—O1 | 112.97 (18) | H17A—C17—H17B | 109.5 |
N2—C8—C9 | 130.30 (19) | C16—C17—H17C | 109.5 |
O1—C8—C9 | 116.72 (17) | H17A—C17—H17C | 109.5 |
O2—C9—C8 | 107.97 (17) | H17B—C17—H17C | 109.5 |
C7—N1—N2—C8 | 0.6 (3) | C7—O1—C8—N2 | −0.2 (2) |
C6—C1—C2—C3 | 0.5 (5) | C7—O1—C8—C9 | 178.65 (17) |
C1—C2—C3—C4 | 0.6 (5) | C10—O2—C9—C8 | 179.63 (16) |
C1—C2—C3—Cl1 | −179.1 (2) | N2—C8—C9—O2 | −8.3 (3) |
C2—C3—C4—C5 | −0.7 (5) | O1—C8—C9—O2 | 173.06 (16) |
Cl1—C3—C4—C5 | 178.9 (2) | C9—O2—C10—C11 | −179.13 (17) |
C3—C4—C5—C6 | −0.1 (5) | C9—O2—C10—C15 | 2.1 (3) |
C4—C5—C6—C1 | 1.1 (4) | O2—C10—C11—C12 | 178.85 (18) |
C4—C5—C6—C7 | 179.9 (2) | C15—C10—C11—C12 | −2.3 (3) |
C2—C1—C6—C5 | −1.3 (4) | C10—C11—C12—C13 | −0.1 (3) |
C2—C1—C6—C7 | 179.9 (2) | C11—C12—C13—C14 | 2.3 (3) |
N2—N1—C7—O1 | −0.8 (3) | C11—C12—C13—N3 | −178.20 (19) |
N2—N1—C7—C6 | 179.2 (2) | C16—N3—C13—C14 | −172.9 (2) |
C8—O1—C7—N1 | 0.6 (2) | C16—N3—C13—C12 | 7.6 (4) |
C8—O1—C7—C6 | −179.32 (18) | C12—C13—C14—C15 | −2.1 (3) |
C5—C6—C7—N1 | −3.4 (4) | N3—C13—C14—C15 | 178.33 (19) |
C1—C6—C7—N1 | 175.5 (2) | C11—C10—C15—C14 | 2.5 (3) |
C5—C6—C7—O1 | 176.6 (2) | O2—C10—C15—C14 | −178.79 (18) |
C1—C6—C7—O1 | −4.6 (3) | C13—C14—C15—C10 | −0.2 (3) |
N1—N2—C8—O1 | −0.3 (2) | C13—N3—C16—O3 | −4.4 (4) |
N1—N2—C8—C9 | −178.9 (2) | C13—N3—C16—C17 | 175.4 (2) |
N-(4-{[5-(4-Chlorophenyl)-1,3,4-oxadiazol-2-yl]methoxy}phenyl)acetamide (II) . Hydrogen-bond geometry (Å, º)
D—H···A | D—H | H···A | D···A | D—H···A |
C1—H1···O1 | 0.93 | 2.54 | 2.853 (3) | 100 |
N3—H3···N2i | 0.86 | 2.55 | 3.377 (3) | 161 |
C1—H1···O3i | 0.93 | 2.46 | 3.359 (3) | 163 |
C14—H14···N2i | 0.93 | 2.59 | 3.443 (3) | 152 |
C17—H17C···O3ii | 0.96 | 2.56 | 3.357 (4) | 140 |
Symmetry codes: (i) −x+3/2, y+1/2, −z+1/2; (ii) x, −y, z+1/2.
Funding Statement
This work was funded by Department of Biotechnology , Ministry of Science and Technology grant BT/PR16268/NER/95/183/2015.
References
- Bruker (2002). SMART, and SAINT. Bruker AXS Inc., Madison, Wisconsin, U. S. A.
- Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849–854.
- Gans, J. D. & Shalloway, D. (2001). J. Mol. Graph. Model. 19, 557–559. [DOI] [PubMed]
- Guimarães, C. R. W., Boger, D. L. & Jorgensen, W. L. (2005). J. Am. Chem. Soc. 127, 17377–17384. [DOI] [PubMed]
- Pace, A. & Pierro, P. (2009). Org. Biomol. Chem. 7, 4337–4348. [DOI] [PubMed]
- Rigo, B. & Couturier, D. J. (1985). Heterocycl. Chem. 22, 287–288.
- Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]
- Sheldrick, G. M. (2015). Acta Cryst. C71, 3–8.
- Spek, A. L. (2009). Acta Cryst. D65, 148–155. [DOI] [PMC free article] [PubMed]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Crystal structure: contains datablock(s) I, II, global. DOI: 10.1107/S2056989018016754/zq2243sup1.cif
Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989018016754/zq2243Isup2.hkl
Structure factors: contains datablock(s) II. DOI: 10.1107/S2056989018016754/zq2243IIsup4.hkl
Supporting information file. DOI: 10.1107/S2056989018016754/zq2243Isup4.cml
Supporting information file. DOI: 10.1107/S2056989018016754/zq2243IIsup5.cml
Additional supporting information: crystallographic information; 3D view; checkCIF report